Abstracts

NASCENT HIV-1 ENV-REACTIVE bNAb INDUCTION IN SHIV-INFECTED NEONATAL RHESUS MACAQUES

Background: Recent studies have indicated that HIV-1 infected infants and children more frequently develop broadly neutralizing antibodies (bnAbs) and do so faster than adults. However, the cellular and molecular mechanisms of infant bnAb development are not fully understood. We sought to develop a neonatal model to reproducibly study bnAb induction. Methods: Thirteen therapy-naïve infant rhesus…

SARS-CoV-2 SEROPREVALENCE AND RISKS FACTORS IN AFRICAN WLHIV ON ART AND THEIR INFANTS

Background: SARS-CoV-2 seroprevalence data in women living with HIV (WLHIV), their infants and associated risk factors in this subpopulation remain limited. We retrospectively measured SARS-CoV-2 seroprevalence from 09/2019-12/2021 among WLHIV and their children in the PROMOTE observational cohort in Uganda, Malawi, and Zimbabwe prior to widespread SARS-CoV-2 vaccination in those countries. Methods: Sociodemographic, clinical data…

MONITORING HIV DUAL-THERAPY IMPLEMENTATION AS REGIMEN SIMPLIFICATION POLICY IN BRAZIL

Background: Long-term exposure to three-drug regimens has been associated with toxic effects such as renal and bone toxicity related to tenofovir (TDF), cardiovascular and metabolic disorders for other ITRN. Since 2019, to minimize toxicity, Brazil recommends two-drug regimens (2-DRs) (3TC+DTG or 3TC+DRVr) for those already on antiretroviral therapy (ART), with undetectable viral load (VL) and…

MODELLING THE MPOX EPIDEMIC IN THE UK OVER MAY-AUGUST 2022

Background: The monkeypox epidemic in the UK began in May 2022. Unexpectedly and rapidly, rates of new cases declined during August 2022. Identifying the causes of this decline requires accurate estimates of the time-varying epidemic growth rate, which in turn depend upon the delay between symptom onset to healthcare presentation. In this paper, we utilise…

LONG-TERM COVID-19 BOOSTER EFFECTIVENESS AND IMMUNE IMPRINTING

Background: Long-term effectiveness of COVID-19 mRNA boosters in populations with different prior infection histories and clinical vulnerability profiles is inadequately understood. Methods: A national, matched, retrospective, target trial cohort study was conducted in Qatar to investigate effectiveness of a third mRNA (booster) dose, relative to a primary series of two doses, against SARS-CoV-2 omicron infection…

EVOLUTION OF CLUSTERS TRANSMISSION PATTERNS IN FRANCE DURING THE LAST DECADE

Background: The recent transmission clusters (RTCs) identified through phylogenetic approaches allow to describe the main transmission networks. This render possible to describe potential shifts among HIV transmission routes and populations and, in some cases, to specifically target prevention measures. Here we describe the evolution of RTCs over the last decade in a specialized laboratory serving…